The analysis found that those using tirzepatide (Zepbound or Mounjaro) lost 1520% of their body weight
It is estimated that some 30-50 percent of children and adults in North America, Europe, Australia, New Zealand, and Asia are deficient
GLP-1 receptor agonists are licensed in the UK for type 2 diabetes mellitus and specific weight management indications, not for cognitive impairment or dementia GLP-1 receptors are present in brain regions involved in memory and learning, prompting research into potential neuroprotective effects Ongoing clinical trials, including studies of semaglutide in Alzheimer's disease, are examining whether these medications benefit cognitive function Common adverse effects include gastrointestinal symptoms
Last updated: January 2026 SOURCE: Ivy RX Source: Ivy RX
You can learn more about milia, how its treated, and when to visit your dermatologist for help managing this skin condition on this page